Key Highlights
- KeyBanc raised RKLB rating to Overweight with $135 price objective, suggesting approximately 40% potential gain
- Nasdaq-100 Index addition confirmed for June 22, 2026
- Neutron rocket program maintains timeline for maiden launch in 2026 following successful resolution of early-year technical issue
- First quarter revenue reached $200.35 million, representing 63.4% annual growth and exceeding Wall Street projections of $189.65 million
- Institutional investors control 71.78% of shares, with several major funds expanding positions during the first quarter
Shares of Rocket Lab (RKLB) reached $102.39 on Monday, posting a 6.50% gain as Wall Street analysts raised their outlook and the company secured its position in a major market index.
KeyBanc Capital Markets initiated coverage with an Overweight rating and established a $135 price objective for RKLB shares. This target price indicates potential upside of approximately 40% from current trading levels. The investment bank maintained its existing financial projections for the company.
The rating improvement arrives as Rocket Lab secures its place in the Nasdaq-100, with the addition taking effect on June 22. Such index memberships typically generate significant buying activity from the more than 200 exchange-traded funds and other investment vehicles that mirror the index, representing collective assets exceeding $800 billion.
KeyBanc highlighted the company’s status as the runner-up in the private space launch industry. The Electron launch vehicle has successfully completed approximately 90 orbital missions to date.
For many market participants, the Neutron rocket program represents the company’s most significant growth catalyst. KeyBanc analysts noted improved transparency regarding the development timeline over recent months and verified that a testing setback encountered in January has been completely addressed. The Neutron vehicle remains scheduled for its inaugural flight before year-end.
Stifel Nicolaus recently elevated its RKLB price objective to $132 from $110 while reaffirming a Buy recommendation, highlighting robust revenue growth and an expanding contract pipeline.
First Quarter Performance Exceeds Projections
On May 7, Rocket Lab disclosed first quarter revenue of $200.35 million, surpassing analyst expectations of $189.65 million. This represented a 63.4% increase compared to the prior-year period.
Earnings per share registered at -$0.07, aligning with consensus forecasts. The aerospace firm recorded a net margin of negative 26.87% and return on equity of negative 11.72%. Wall Street anticipates full-year EPS of -$0.29.
The equity has appreciated more than 300% over the trailing twelve months. Trading has occurred between a 52-week range of $25.24 and $151.00, with shares currently positioned approximately 24% beneath the recent peak. The 50-day moving average stands at $101.62.
Institutional Investors Continue Accumulating Shares
Institutional shareholders account for 71.78% of outstanding RKLB stock. During the first quarter, AQR Capital Management expanded its holdings by more than 100%, acquiring an additional 92,849 shares. NewEdge Advisors dramatically increased its position by over 1,800%. UBS Asset Management purchased 90,758 shares, elevating its total ownership to 773,548 shares.
Entropy Technologies LP grew its investment by 18.5% in the fourth quarter, accumulating 55,117 shares valued at approximately $3.85 million.
Regarding insider transactions, Director Alexander Slusky divested 100,000 shares on May 12 at $118.08 per share, decreasing his holdings by 18.7%. Insider Marvin Bradford Clevenger sold 15,549 shares on May 26 at $142.57 each, with the transaction attributed to tax liabilities associated with vested equity compensation.
Wall Street sentiment leans decidedly bullish. Among covering analysts, twelve assign Buy ratings, three recommend Strong Buy, five suggest Hold, and one advises Sell. The average price target across analysts reaches $102.76.
The stock has additionally gained from heightened interest in space-sector equities following SpaceX’s recent Nasdaq listing, as investors reallocate capital toward aerospace-related opportunities.





